Overview
Martin Sanda is an Urologist in Atlanta, Georgia. Dr. Sanda has been practicing medicine for over 38 years and is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Urinary Incontinence, Prostatectomy, and Vasectomy.
His clinical research consists of co-authoring 124 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Familial Prostate Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
5673 Peachtree Dunwoody Road, Ste350A, Atlanta, GA 30342
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Wellstar Medical Group LLC
Martha Terris is an Urologist in Kennesaw, Georgia. Dr. Terris is rated as an Elite provider by MediFind in the treatment of Familial Prostate Cancer. Her top areas of expertise are Prostate Cancer, Bladder Cancer, Renal Cell Carcinoma (RCC), Prostatectomy, and Nephrectomy. Dr. Terris is currently accepting new patients.
Piedmont Providers LLC
Spencer Kozinn is an Urologist in Atlanta, Georgia. Dr. Kozinn is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Bladder Cancer, Reconstructive Urology Surgery, and Nephrectomy. Dr. Kozinn is currently accepting new patients.
Georgia Urology, PA
Joel Rosenfeld is an Urologist in Atlanta, Georgia. Dr. Rosenfeld is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Urinary Tract Infection in Children, Nephrectomy, and Reconstructive Urology Surgery. Dr. Rosenfeld is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Prostate CancerDr. Sanda isElite. Learn about Prostate Cancer.
- Distinguished
- Familial Prostate CancerDr. Sanda isDistinguished. Learn about Familial Prostate Cancer.
- ProstatectomyDr. Sanda isDistinguished. Learn about Prostatectomy.
- Urinary IncontinenceDr. Sanda isDistinguished. Learn about Urinary Incontinence.
- Advanced
- Erectile Dysfunction (ED)Dr. Sanda isAdvanced. Learn about Erectile Dysfunction (ED).
- Experienced
- Bladder CancerDr. Sanda isExperienced. Learn about Bladder Cancer.
- Bowel IncontinenceDr. Sanda isExperienced. Learn about Bowel Incontinence.
- Enlarged Prostate (BPH)Dr. Sanda isExperienced. Learn about Enlarged Prostate (BPH).
- LymphadenectomyDr. Sanda isExperienced. Learn about Lymphadenectomy.
- Muscle Invasive Bladder CancerDr. Sanda isExperienced. Learn about Muscle Invasive Bladder Cancer.
- Non-Muscle Invasive Bladder CancerDr. Sanda isExperienced. Learn about Non-Muscle Invasive Bladder Cancer.